New Perspectives for Generic Pharmaceutical Industry 2016 is a course that provides knowledge on the current situation in the generic pharma industry.
Topics
- Post patent cliff arena
- Pharma industry on the move
- Supergenerics vs Generics
- Sustainable product portfolio strategies
- Decreasing prices vs sustainable generics model
- Case studies on value added generics
- Generics in 2020 and beyond
- Commercial strategies for succesful market access
Who should Attend
Attendees from pharmaceutical, bio-chemical, bio-technology and Health Care:
- Business developers
- Industries: , Industry advisors
- Heads of R&D
- Strategic planners
- International & Governmental affairs
- Market access
- M&A
- Investor relations
- Heads of pharma technology startups
- Intellectual property
- Licensing
- Pricing & reimbursement
- Health economists
- Academics
